FN-1501|1429515-59-2|-陌孚医药/Medlife

您当前的位置：

FN-1501

目录号: PL01894 纯度: ≥99%

CAS No. :1429515-59-2

商品编号	规格	价格	会员价
PL01894-5mg	5mg	¥4018.00	请登录
PL01894-10mg	10mg	¥7232.00	请登录
PL01894-50mg	50mg	¥22501.00	请登录
PL01894-100mg	100mg	¥33752.00	请登录
PL01894-200mg	200mg	询价	询价
PL01894-500mg	500mg	询价	询价
PL01894-10mM*1mLinDMSO	10mM*1mLinDMSO	¥4420.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	FN-1501
中文别名	4-(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)-N-(4-(4-甲基哌嗪-1-基)甲基)苯基)-1H-吡唑-3-甲酰胺
英文名称	FN-1501
英文别名	TQR1001;BDBM50270304;6MC966B505;4((7HPyrrolo[2,3d]pyrimidin-4-yl)amino)N(4-((4-methylpiperazin-1-yl)methyl)phenyl)1Hpyrazole-3-carboxamide;4-((7H-Pyrrolo (2,3-d)pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide;4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-5-carboxamide;4a?(7Ha'Pyrrolo[2,3a'd]pyrimidin-4-yl)amino)a'Na?4-((4-methy;CID 72195175;FN-1501
Cas No.	1429515-59-2
分子式	C₂₂H₂₅N₉O
分子量	431.49
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情

FN-1501 是一种有效的 FLT3 和 CDK 抑制剂，对 CDK2/cyclin A，CDK4/cyclin D1，CDK6/cyclin D1 和 FLT3 的 IC₅₀ 值分别为 2.47，0.85，1.96, 和 0.28 nM。FN-1501 具有抗肿瘤的活性。

生物活性

FN-1501 is a potent inhibitor of FLT3 and CDK, with IC 50 s of 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively. FN-1501 has anticancer activity.

性状

Solid

IC50 & Target[1][2]

Cdk4/cyclin D1 0.85 nM (IC50) CDK6/cyclinD1a

体外研究(In Vitro)

FN-1501 is a potent inhibitor of FLT3 and CDK, with IC50s of 2.47 ± 0.21, 0.85 ± 0.28, 1.96 ± 0.08 and 0.28 ± 0.01 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively. FN-1501 shows potent inhibitory activity against several tumor cells, such as MGC803, RS4;11, MCF-7, HCT-116, and NCI-H82, with GI50s of 0.37 ± 0.04, 0.05 ± 0.01, 2.84 ± 0.25, 0.09 ± 0.04, 0.11 ± 0.02 nM, respectively. has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

FN-1501 exhibits potent antitumor activity, and shows little cytotoxicity on normal lymphocyte cells, with LD 50 of 185.67 mg/kg in ICR mice. FN-1501 (15. 30, or 40 mg/kg/d, i.v.) dose-dependently and significantly suppresses the growth of tumor in MV4-11-cell-inoculated-xenograft mice. has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder -20°C 3 years；4°C 2 years

ClinicalTrial

参考文献

[1]. Wang Y, et al. Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia.

溶解度数据	In Vitro: DMSO : ≥ 50 mg/mL (115.88 mM)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation